Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Connection

Ha-Neui Kim to Histone Deacetylase Inhibitors

This is a "connection" page, showing publications Ha-Neui Kim has written about Histone Deacetylase Inhibitors.

 
Connection Strength
 
 
 
1.125
 
  1. Kim HN, Lee JH, Jin WJ, Ko S, Jung K, Ha H, Lee ZH. MS-275, a benzamide histone deacetylase inhibitor, prevents osteoclastogenesis by down-regulating c-Fos expression and suppresses bone loss in mice. Eur J Pharmacol. 2012 Sep 15; 691(1-3):69-76.
    View in: PubMed
    Score: 0.408
  2. Kim HN, Lee JH, Bae SC, Ryoo HM, Kim HH, Ha H, Lee ZH. Histone deacetylase inhibitor MS-275 stimulates bone formation in part by enhancing Dhx36-mediated TNAP transcription. J Bone Miner Res. 2011 Sep; 26(9):2161-73.
    View in: PubMed
    Score: 0.383
  3. Kim HN, Ha H, Lee JH, Jung K, Yang D, Woo KM, Lee ZH. Trichostatin A inhibits osteoclastogenesis and bone resorption by suppressing the induction of c-Fos by RANKL. Eur J Pharmacol. 2009 Nov 25; 623(1-3):22-9.
    View in: PubMed
    Score: 0.334
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.